Lipid Biomarkers for Cancer Screening and Monitoring

Case ID:
UA19-125
Invention:

This invention relates to mechanisms and biomarkers for early detection of potentially aggressive cancers. These biomarkers are useful in determining the aggressiveness and drug resistance of existing cancers. 

 

Background:

There is a need for a better, more convenient way to detect cancers to help reduce unnecessary biopsies and negative treatment side effects.

  

Applications:

  • Early detection of potentially aggressive cancers
  • Identification of cancer aggressiveness and drug resistance
  • Monitoring disease progress and drug resistance once disease has been diagnosed

Advantages:

  • Ability to identify cancer in people prior to exhibiting symptoms
  • Determine the mechanism of action driving a disease
  • Predict future health outcomes
  • An ideal screening test will reduce the risk of death from cancer and lead to a longer overall life
Patent Information:
Contact For More Information:
Tod McCauley
Assistant Director of Licensing, CALS
The University of Arizona
520-621-9493
todm@tla.arizona.edu
Lead Inventor(s):
Floyd Chilton
Ashley Snider
Justin Snider
Keywords: